Clinical Scores, Biomarkers, and CT Findings in Acute Pulmonary Embolism
PEST
Comparing Clinical Scores, Biomarkers, and CT Findings in Patients With Acute Pulmonary Embolism Across Different Hospital Departments
1 other identifier
observational
50
0 countries
N/A
Brief Summary
This study aims to compare clinical scoring systems, laboratory biomarkers, and computed tomography (CT) findings in patients diagnosed with acute pulmonary embolism in different hospital departments. The study will include patients diagnosed with acute pulmonary embolism at Sohag University Hospital. Clinical data, laboratory results, and imaging findings will be collected and analyzed to evaluate their diagnostic and prognostic value. The goal of this research is to identify the most reliable and practical tools for early diagnosis and risk stratification of acute pulmonary embolism, which may help improve patient management and outcomes. This is an observational study and does not involve any intervention or change in standard patient care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
May 5, 2026
April 1, 2026
1 year
April 4, 2026
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants with In-Hospital All-Cause Mortality
All-cause mortality among adult patients with confirmed acute pulmonary embolism, defined as death from any cause occurring during hospitalization. The outcome will be assessed as the number of participants who die before hospital discharge.
Up to 30 days
Study Arms (1)
Acute Pulmonary Embolism Group
This cohort includes patients diagnosed with acute pulmonary embolism at Sohag University Hospital. Participants will be evaluated using clinical scoring systems, laboratory biomarkers, and computed tomography pulmonary angiography (CTPA) findings. No interventions will be applied, and all data will be collected as part of routine clinical care for observational analysis.
Interventions
This is an observational study with no active intervention. All data are collected from routine clinical care, including clinical scoring systems, laboratory biomarkers, and computed tomography pulmonary angiography (CTPA) findings in patients with acute pulmonary embolism.
Eligibility Criteria
Adult patients with confirmed acute pulmonary embolism admitted to Sohag University Hospital from different departments including Emergency, ICU, Medical, and Surgical wards.
You may qualify if:
- Adults aged ≥ 18 years
- Confirmed acute pulmonary embolism by CTPA
You may not qualify if:
- Chronic pulmonary embolism
- Non-diagnostic CTPA
- Refusal to participate
- Severe renal impairment precluding contrast-enhanced CT
- Known hypersensitivity to contrast media
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident of Chest Diseases
Study Record Dates
First Submitted
April 4, 2026
First Posted
May 5, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
May 5, 2026
Record last verified: 2026-04